|   
    | 
      
     | 
 
 |  
    
   
    | 
       
        À¯·áȸ¿ø °áÀç½Ã¿¡´Â º¸´Ù ´Ù¾çÇÑ ¾à¹°Á¤º¸¸¦
        ÀÌ¿ëÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
        À¯·áÁ¤º¸¸ñ·ÏÀº Àü¹®È¸¿øÀ¸·Î
        ·Î±×ÀÎ ÇϽøé È®ÀÎ °¡´ÉÇÕ´Ï´Ù.
       
     | 
   
  
     | 
   
  
  
    
      
  
    
       |  
      
        
          
            
                | Çã°¡Á¤º¸ | 
             
           
         | 
       
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
  
  
  
   
    û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå  »óÇÑ±Ý¾× | 
    
      
      
        
        644904620  
	    
	    
            [º¸ÇèÄڵ忡 µû¸¥ ¾àǰ±âº»Á¤º¸ Á÷Á¢Á¶È¸] 
          
        
        
        
                    [ºñ±Þ¿©]
                
       
      
       
       
     
      
      
     
      
    
    
    
      
     [»óº´ÄÚµåÁ¶È¸]
      
      [Áúº´ÄÚµåÁ¶È¸]
     
     | 
   
   
    | ºü¸¥Á¶È¸ | 
    
      
     |   
   
  
  
  
   
    | Á¦Ç°¼º»ó | 
    Àû°¥»öÀÇ À¯»ó¹°ÁúÀÌ µé¾î ÀÖ´Â ¾ç¸é ºÒÅõ¸íÇÑ Àû°¥»öÀÇ Å¸¿øÇü ¿¬Áúݼ¿Á¦  [Á¦ÇüÁ¤º¸ È®ÀÎ] |   
   
  
  
  
  
  
  
  
  
  	
   
    | ÁÖ¼ººÐÄÚµå | 
    
      B90400ACS  
      
	  [µ¿ÀÏÇÑ ÁÖ¼ººÐÄڵ带 °¡Áø ¿À¸®Áö³¯ ¶Ç´Â Á¦³×¸¯ ÀǾàǰ Á¶È¸]
     | 
   
  
  
  
 
  
  
    
  
  
  
  
  
  
  
  
  
  
 
  
  
  
 
  
  
  
  
  
  
   
    | Çã°¡»çÇ× ¿ø¹®Á¶È¸ | 
    
      
	    [Çã°¡»çÇ× ¿ø¹®Á¶È¸] 
     | 
   
  
  
  
  
     
  
  
  
   
    | È¿´ÉÈ¿°ú | 
    
    [ÀûÀÀÁõ º° °Ë»ö] 
      
    
     
	 
      ´ÙÀ½ °æ¿ìÀÇ ºñŸ¹Î A, E, C ÀÇ º¸±Þ 
- À°Ã¼ÇÇ·Î 
- ÀӽŤý¼öÀ¯±â 
- º´Áߤýº´ÈÄ(º´À» ¾Î´Â µ¿¾ÈÀ̳ª ȸº¹ ÈÄ)ÀÇ Ã¼·ÂÀúÇϽà 
- ³ë³â±â 
- ´«ÀÇ °ÇÁ¶°¨ÀÇ ¿ÏÈ 
- ¾ß¸ÍÁõ(¹ã¿¡ Àß ¸øº¸´Â Áõ»ó) 
- ¸»ÃÊÇ÷ÇàÀå¾Ö ¹× °»³â±â½Ã ´ÙÀ½ Áõ»óÀÇ ¿ÏÈ : ¾î±ú¤ý¸ñ°á¸², ¼öÁ·Àú¸²¤ý¼öÁ·³ÃÁõ(¼Õ¹ßÀÌ Â÷°¡¿ò) 
- ÇÞºû¤ýÇǺκ´ µî¿¡ ÀÇÇÑ »ö¼ÒÄ§Âø(±â¹Ì, ÁÖ±Ù±ú)ÀÇ ¿ÏÈ 
- ÀÕ¸öÃâÇ÷¤ýºñÃâÇ÷(ÄÚÇÇ) ¿¹¹æ 
- ¾Æ¿¬ÀÇ º¸±Þ 
      
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
    
  
  
  
  
  
   
    | ¿ë¹ý¿ë·® | 
    
      * Àý´ë ÀÓÀǺ¹¿ëÇÏÁö ¸¶½Ã°í ¹Ýµå½Ã ÀÇ»ç ¶Ç´Â ¾à»ç¿Í »ó´ãÇϽñ⠹ٶø´Ï´Ù. 
    
     
      
      
      [󹿾à¾î] 
      ¼ºÀÎ 1ÀÏ 2ȸ, 1ȸ 1 ĸ½¶À» ½ÄÈÄ¿¡ º¹¿ëÇÑ´Ù.      
      	
     | 
   
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
   
    | ±Ý±â | 
    1) ÀÌ ¾à ¹× ÀÌ ¾à¿¡ Æ÷ÇÔµÈ ¼ººÐ¿¡ °ú¹Î¹ÝÀÀÀÌ Àִ ȯÀÚ 
2) Àª½¼º´ 
3) ¸¸ 12°³¿ù ¹Ì¸¸ÀÇ Á¥¸ÔÀÌ 
4) ´ëµÎÀ¯¿¡ °ú¹ÎÇϰųª ¾Ë·¹¸£±â º´·ÂÀÌ Àִ ȯÀÚ 
5) Äá ¶Ç´Â ¶¥Äá¿¡ °ú¹ÎÁõÀÌ Àִ ȯÀÚ  | 
   
  
  
  
  
   
    | ½ÅÁßÅõ¿© | 
    1) ÀÇ»çÀÇ Ä¡·á¸¦ ¹Þ°í Àִ ȯÀÚ 
2) °í¿Á»ì»ê´¢Áõ ȯÀÚ(hyperoxaluria : ¿äÁß¿¡ °ú·®ÀÇ ¼ö»ê¿°ÀÌ ¹è¼³µÇ´Â »óÅÂ) 
3) ÀӺΠ¹× ÀÓ½ÅÇϰí ÀÖÀ» °¡´É¼ºÀÌ ÀÖ´Â ¿©¼º, ¼öÀ¯ºÎ, ¹Ì¼÷¾Æ, À¯¾Æ 
¨ç ¿Ü±¹¿¡¼ ÀÓ½ÅÀü 3°³¿ùºÎÅÍ ÀÓ½ÅÃʱâ 3°³¿ù±îÁö ºñŸ¹Î A¸¦ 10,000 IU/ÀÏ ÀÌ»ó ¼·ÃëÇÑ ¿©¼ºÀ¸·ÎºÎÅÍ ÅÂ¾î³ ¾ÆÀÌ¿¡¼ µÎºÎ½Å°æ¸ª µîÀ» Áß½ÉÀ¸·Î ÇÏ´Â ±âÇü¹ßÇö(±âÇü¹ß»ý) Áõ°¡°¡ ÃßÁ¤µÈ´Ù´Â ¿ªÇÐÁ¶»ç°á°ú°¡ ÀÖÀ¸¹Ç·Î ÀӽŠ3°³¿ùÀ̳» ¶Ç´Â ÀÓ½ÅÇϰí ÀÖÀ» °¡´É¼ºÀÌ ÀÖ´Â ¿©¼º¿¡´Â ºñŸ¹Î A °áÇÌÁõÄ¡·á¿¡ »ç¿ëÇÏ´Â °æ¿ì¸¦ Á¦¿ÜÇϰí´Â ÀÌ ¾àÀ» Åõ¿©ÇÏÁö ¾Ê´Â´Ù. ¶ÇÇÑ ºñŸ¹Î A º¸±ÞÀ» ¸ñÀûÀ¸·Î ÀÌ ¾àÀ» »ç¿ëÇÏ´Â °æ¿ì´Â ½Äǰ µîÀ¸·ÎºÎÅÍÀÇ ¼·Ãë·®¿¡ ÁÖÀÇÇϰí ÀÌ ¾à¿¡ ÀÇÇÑ ºñŸ¹Î A Åõ¿©´Â 5,000 IU/ÀÏ ¹Ì¸¸¿¡ ¸Ó¹°µµ·Ï ÇÏ´Â µî ÀûÀýÇÑ ÁÖÀǸ¦ ÇÑ´Ù. 
4) ¼Òȼº±Ë¾ç, ¸¸¼º±Ë¾ç¼º´ëÀå¿°, ±¹ÇѼº´ëÀå¿° µîÀÇ À§ÀåÁúȯ ȯÀÚ 
5) ½ÉÀå¤ý¼øÈ¯±â°è±â´É Àå¾Ö ȯÀÚ 
6) ½ÅÀåÀå¾Ö ȯÀÚ 
7) Àú´Ü¹éÇ÷Áõ ȯÀÚ 
8) ´ã³¶(¾µ°³)°ü·Ã Áúȯ, °£Áúȯ ȯÀÚ 
9) ÅëdzȯÀÚ ¶Ç´Â ½ÅÀå°á¼®ÀÌ Àִ ȯÀÚ 
10) °íÁö´Ü¹éÇ÷Áõ, ´ç´¢º´¼º°íÁöÁúÇ÷Áõ ¹× ÃéÀå¿° µî Áö¹æ´ë»ç ÀÌ»ó ȯÀÚ ¶Ç´Â ÁöÁú¼º À¯Á¦¸¦ ½ÅÁßÈ÷ Åõ¿©ÇØ¾ß Çϴ ȯÀÚ  | 
   
  
    
  
  
  
  
  
   
    | ÀÌ»ó¹ÝÀÀ | 
    
       ´ÙÀ½°ú °°Àº °æ¿ì ÀÌ ¾àÀÇ º¹¿ëÀ» Áï°¢ ÁßÁöÇϰí ÀÇ»ç, Ä¡°úÀÇ»ç, ¾à»ç¿Í »óÀÇÇÒ °Í. »ó´ã ½Ã °¡´ÉÇÑ ÇÑ ÀÌ Ã·ºÎ¹®¼¸¦ ¼ÒÁöÇÒ °Í. 
1) ÀÌ ¾àÀÇ Åõ¿©¿¡ ÀÇÇÏ¿© ´ÙÀ½ÀÇ Áõ»óÀÌ ÀÖÀ» °æ¿ì 
±¸¿ª, ±¸Åä, °¡·Á¿ò, °ÇÁ¶ÇÏ°í °ÅÄ£ ÇǺÎ, ÅëÁõ¼º °üÀýºÎÁ¾, À§ºÎºÒÄè°¨, ¼³»ç, º¯ºñ, ¹ßÁø, ¹ßÀû, »óº¹ºÎ ÅëÁõ, È¥¼ö, ÇǺο°, ¶¡¤ýÈ£Èí½Ã ¾ÇÃë, Å»¸ð, Á¶±ÞÁõ, À§Àå°üÀå¾Ö, ¼ÒÈÀå¾Ö, ÀúÇ÷¾Ð, ÆóºÎÁ¾ 
2) ÀÌ ¾àÀÇ Åõ¿©¿¡ ÀÇÇÏ¿© »ý¸®°¡ ¿¹Á¤º¸´Ù »¡¶óÁö°Å³ª ¾çÀÌ Á¡Á¡ ¸¹¾ÆÁú ¼ö ÀÖÀ¸¸ç, ÃâÇ÷ÀÌ ¿À·¡ Áö¼ÓµÉ ¼ö ÀÖ´Ù. 
3) ¿¡½ºÆ®·Î°ÕÀ» Æ÷ÇÔÇÑ °æ±¸¿ë ÇÇÀÓÁ¦¸¦ º¹¿ëÇÏ´Â ¿©¼º ¶Ç´Â Ç÷Àü¼º ¼ÒÀÎÀÌ Àִ ȯÀÚ°¡ ºñŸ¹Î E¸¦ º¹¿ëÇÒ °æ¿ì Ç÷ÀüÁõÀÇ À§ÇèÀÌ Áõ°¡µÉ ¼ö ÀÖ´Ù. 
4) Àå±â°£ °í¿ë·®À» Åõ¿©ÇÒ °æ¿ì ³»¼ºÀÌ »ý±æ ¼ö ÀÖ´Ù. 
5) ´ë·®Åõ¿©·Î ÀÎÇØ ±¸¿ª, ±¸Åä µîÀÇ À§ÀåÁõ»ó, °í³ªÆ®·ýÇ÷Áõ, ¿ïÇ÷½ÉºÎÀü, ºÎÁ¾(ºÎ±â) µîÀÇ Áõ»óÀÌ ³ªÅ¸³¯ ¼ö ÀÖ´Ù. 
6) Àå±â°£ °í¿ë·®ÀÇ ºñŸ¹Î A(º£Å¸Ä«·ÎƾÀ¸·ÎºÎÅÍ ÀüȯµÈ °ÍÀ» Á¦¿ÜÇÑ) ¼·Ãë´Â Æó°æ±â¸¦ Áö³ ¿©¼ºÀÇ °ñ´Ù°øÁõ(»À¾û¼ºÁõ) À§ÇèÀ» ³ôÀÏ ¼ö ÀÖ´Ù. 
7) Ç׾˵µ½ºÅ×·ÐÁ¦, Æ®¸®¾ÏÅ×·»°ú º´¿ëÅõ¿©½Ã °íÄ®·ýÇ÷ÁõÀ» ÀÏÀ¸Å³ ¼ö ÀÖÀ¸¹Ç·Î ÁÖÀÇÇÒ °Í. 
8) ¿ì¹ßÀûÀ¸·Î °ú·®º¹¿ë ÇÑ °æ¿ì 
9) 1°³¿ù Á¤µµ º¹¿ëÇÏ¿©µµ Áõ»óÀÇ °³¼±ÀÌ ¾øÀ» °æ¿ì 
      
     | 
   
        
  
  
    
   
    | »óÈ£ÀÛ¿ë | 
    ÀÌ ¾àÀ» º¹¿ëÇÏ´Â µ¿¾È ´ÙÀ½ÀÇ ¾àÀ» º¹¿ëÇÏÁö ¸» °Í. 
1) Àλ꿰, Ä®½·¿°, °æ±¸¿ë Åׯ®¶ó»çÀÌŬ¸°°è Á¦Á¦, Á¦»êÁ¦  | 
   
  
    
  
  
       	
  
  
   
    | Off-label Usage | 
    
      
	[Á¶È¸]    
     | 
   
     
  
  
  
  
  
   
    | Related FDA Approved Drug | 
    
      
      ±âÁØ ¼ººÐ: ASCORBIC ACIDBEROCCA PN (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN E) 
CERNEVIT-12 (ALPHA-TOCOPHEROL; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A) 
INFUVITE ADULT (ALPHA-TOCOPHEROL ACETATE; ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A PALMITATE; VITAMIN K) 
INFUVITE PEDIATRIC (ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K) 
INFUVITE PEDIATRIC (PHARMACY BULK PACKAGE) (ASCORBIC ACID; BIOTIN; CHOLECALCIFEROL; CYANOCOBALAMIN; DEXPANTHENOL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; TOCOPHEROL ACETATE; VITAMIN A; VITAMIN K) 
M.V.C. 9+3 (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
M.V.I. ADULT (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K) 
M.V.I. ADULT (PHARMACY BULK PACKAGE) (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E; VITAMIN K) 
M.V.I. PEDIATRIC (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
M.V.I.-12 (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
M.V.I.-12 (WITHOUT VITAMIN K) (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
M.V.I.-12 LYOPHILIZED (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE; VITAMIN A; VITAMIN E) 
MOVIPREP (ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE) 
MVC PLUS (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E) 
VITAPED (ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PANTOTHENIC ACID; PHYTONADIONE; PYRIDOXINE; RIBOFLAVIN; THIAMINE; VITAMIN A PALMITATE; VITAMIN E) 
        
     | 
      
  
  
  |  
     
   
  
    
       |  
      
        
          
            
                | Á¤º¸¿ä¾à |         
             
           
         | 
             	    
       |  
      | 
  
    µå·°ÀÎÆ÷ ÀǾàǰ ¿ä¾à/»ó¼¼Á¤º¸
    
  
  
    
  
   |  
     
   
  
    
       |  
      
        
          
            
                | ÄÚµå ¹× ºÐ·ùÁ¤º¸ |         
             
           
         | 
             	    
       |  
      | 	 |  
     
   
  
    
       |  
      
        
          
            
                | Á¦Ç°Á¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
   
  
    
       |  
      
        
          
            
                | º¹¾àÁ¤º¸ |            
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
   
    | LACTmed ¹Ù·Î°¡±â | 
    
      
        [¹Ù·Î°¡±â]
     | 
     
  
  
   
    | ¾à¸®ÀÛ¿ë | 
    
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
       
     | 
     
  
  
       
  
  
   
    | º¹¾àÁöµµ | 
    
     
    À¯·áÁ¤º¸ÀÔ´Ï´Ù.
    
     | 
   
                                                          															
  
   
  
  
   
    | ÀӺο¡´ëÇÑÅõ¿© | 
    
      
      
        
	      
	      
	        | *  | 
	        
	          ÀüüÀӽŠ±â°£º°·Î ¿©·¯µî±ÞÀÌ Á¸ÀçÇÒ ¼ö ÀÖÀ¸¸ç °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ º¸¿©Áý´Ï´Ù. ´Ü, º¹ÇÕÁ¦ÀÇ °æ¿ì ¸ðµç º¹ÇÕÁ¦¼ººÐ¿¡ ´ëÇÑ ÀÓºÎÅõ¿©µî±ÞÀÌ Ç¥½ÃµÈ°ÍÀº Àý´ë ¾Æ´Ï¸ç Ç¥½ÃµÈ°ÍÁß¿¡ °¡Àå À§Çèµµ°¡ ³ôÀº Á¤º¸¸¸ ³ªÅ¸³³´Ï´Ù. 
	         | 
	         
	       
	       | 
	   
	  
	    |   | 
	   
	  
	    
	      FDA : Cµî±Þ 
				        
				         (°ú·® Åõ¿©ÇÒ °æ¿ì )
				        
	   | 
	  
	  
	  
	     
	     
	     
	     
	     
	     
	   | 
	 
	
	  
	      
	      
	        | *  | 
	        
	          »ó±â ÀÓºÎÅõ¿©¿¡ ´ëÇÑ Á¤º¸´Â Àü»êó¸® µÇ¸é¼ ÀÔ·Â ¿À·ù °¡´É¼ºÀÌ Á¸ÀçÇÕ´Ï´Ù. ¿À·ù °¡´É¼ºÀ» ÃÖ¼ÒÈÇϱâ À§ÇÏ¿© ¸¹Àº ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸³ª, ±× Á¤È®¼º¿¡ ´ëÇÏ¿© È®½ÅÀ» µå¸± ¼ö ¾ø½À´Ï´Ù. ÀÌ¿¡ ´ëÇØ ȸ»ç´Â Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù.
	         | 
	         
	      
	        | *  | 
	        
	          ¹Ýµå½Ã °ø½Å·Â ÀÖ´Â ¹®ÇåÀ» ´Ù½Ã Çѹø Âü°í ÇϽñ⠹ٶó¸ç ÀÇ»ç ¶Ç´Â ¾à»çÀÇ ÆÇ´Ü¿¡ µû¶ó Åõ¿©¿©ºÎ°¡ °áÁ¤µÇ¾î¾ß ÇÕ´Ï´Ù.
	         | 
	         
	       
	   | 
	 
       
     | 
   
  
  
  	   
  
  	   
  
  	   
  
  
     
      | Pharmacokinetics | 
      
       
      À¯·áÁ¤º¸ÀÔ´Ï´Ù.
      
       |   
     
  
  
  
  
  
  
  
   
    | º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸ | 
    
      [º´¿ë±Ý±â ¹× ¿¬·É´ë±Ý±â ±Ù°ÅÁ¶È¸]
     | 
   
  	
  
  
  	
  
  
  
   
    | º¸°ü»ó ÁÖÀÇ | 
    
      
    	
     | 
   
  
  
   
    | Á¶Á¦½Ã ÁÖÀÇ | 
    
      
    	
     | 
      
 
 |  
     
   
  
    
       |  
      
        
          
            
                | ½É»çÁ¤º¸ |            
             
           
         | 
             	  
       |  
       |  
     
     
  
    
       |  
      
        
          
            
                | ÇмúÁ¤º¸ |          
             
           
         | 
             	  
       |  
      
  
    | Ç׸ñ | 
    ³»¿ë | 
   
  
    | DUR (ÀǾàǰ»ç¿ëÆò°¡) | 
    º´¿ë±Ý±â :
     
	 °í½ÃµÈ º´¿ë±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
	 
	  [»óÈ£ÀÛ¿ë/º´¿ë±Ý±â°Ë»ö]										
	  ¿¬·É´ë±Ý±â :
      °í½ÃµÈ ¿¬·É±Ý±â ³»¿ëÀº ¾ø½À´Ï´Ù.
      
       [¿¬·É´ë±Ý±â»ó¼¼°Ë»ö]
       
       
        
        
     | 
   
  
   
    | µ¶¼ºÁ¤º¸ | 
    Ascorbic Acid¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â 
Beta-carotene¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â 
Zinc oxide¿¡ ´ëÇÑ µ¶¼ºÁ¤º¸ : Á¤º¸º¸±â 
  Ãâó: ±¹¸³µ¶¼º°úÇпø µ¶¼º¹°ÁúÁ¤º¸DB : http://www.nitr.go.kr/nitr/contents/m134200/view.do  | 
   
  
   
    | Pharmacokinetics | 
    
       Beta-carotene 30% emulsionÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á 
- ÀÛ¿ë¹ßÇö½Ã°£ : °æ±¸ : 2-4ÁÖ
 - ÀÛ¿ëÁö¼Ó½Ã°£ : °æ±¸ : ¹Ýº¹ Åõ¿©½Ã : 1-2ÁÖ
 - Èí¼ö : Àå°ü ³»¿¡ Áö¹æ ¹× ´ãÁóÀÌ Á¸ÀçÇÒ ¶§ Èí¼ö°¡ ÀߵȴÙ.
 - ºÐÆ÷ : ü³» ³Î¸® ºÐÆ÷ÇÑ´Ù. (ºñÀå, °£, °ñ¼ö, ¸Á¸·, ½ÅÀå, ÇÇÇÏÁö¹æ µî)
 - ´ë»ç : ÁÖ·Î Àå°ü º®¿¡¼ (¾à 50-60%) ºñŸ¹Î A·Î ´ë»çµÇ¸ç °£¿¡¼µµ ¼Ò·® ´ë»çµÈ´Ù.
 - ¼Ò½Ç : ÁÖ·Î ´ëº¯À» ÅëÇØ, ÀϺδ ´¢¸¦ ÅëÇØ ¹è¼³µÈ´Ù.
  
 D-¥á-tocopherolÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á 
- Èí¼ö : °æ±¸ : 
	
	- ¼ÒÀåÀ¸·ÎºÎÅÍ Èí¼öµÇ´Â µ¥¿¡´Â ´ãÁóÀÌ ÇÊ¿äÇÏ´Ù.
	
 - Èí¼ö ÀúÇÏ : Èí¼öÀå¾Ö ȯÀÚ, ÀúüÁß ¹Ì¼÷¾Æ, °í¿ë·® Åõ¿©
	
 - À¯ÈÁ¦Á¦º¸´Ù ¼ö¿ë¼º Á¦Á¦°¡ ´õ Àß Èí¼öµÈ´Ù.
	
  
 - ºÐÆ÷ : ¸ðµç Á¶Á÷¿¡ ºÐÆ÷Çϸç, ƯÈ÷ Áö¹æÁ¶Á÷¿¡ °í³óµµ·Î ºÐÆ÷Çϰí ÀúÀåµÈ´Ù.
 - ´ë»ç : °£¿¡¼ glucuronides Æ÷ÇÕ
 - ¼Ò½Ç : ÁÖ·Î ´ãÁóÀ» ÅëÇØ (70-80%) ¹è¼³µÈ´Ù.
  
 Ascorbic AcidÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á 
- Èí¼ö : 
	
	- ¼ÒÀå¿¡¼ °ÅÀÇ ¿ÏÀüÈ÷ Èí¼öµÈ´Ù.
	
 - Èí¼ö´Â ´Éµ¿¼ö¼ÛÀ» ÅëÇØ ÀÌ·ç¾îÁö¸ç ¿ë·®ÀÇÁ¸ÀûÀÌ¶ó ¿©°ÜÁø´Ù.  (°í¿ë·®¿¡¼ Èí¼ö Æ÷È)
	
  
 - ºÐÆ÷ : ³Î¸® ºÐÆ÷
 - ´Ü¹é°áÇÕ : ¾à 25%
 - ´ë»ç : °£¿¡¼ »êÈ ¹× Ȳ»ê Æ÷ÇÕ µîÀ¸·Î ´ë»çµÈ´Ù.
 - ¹Ý°¨±â : 16ÀÏ
	
 - Ç÷ÁßÃÖ°í³óµµ µµ´Þ½Ã°£ : Á¤»ó ¼ºÀÎ : 2-3 ½Ã°£
 - ¼Ò½Ç :
	
 
	- ÁÖ ¹è¼³ °æ·Î´Â ½ÅÀå ¹× ´ãÁóÀÌ´Ù.
	
 - ½Å¹è¼³Àº ¿ë·®ÀÇÁ¸ÀûÀ¸·Î, Åõ¿©·®ÀÌ Áõ°¡ÇÏ¸é ½Å¹è¼³·® ¹× ¼Óµµ°¡ Áõ°¡ÇÑ´Ù.
	
  
  
 Selenium 0.1% powderÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á 
-  ü³»ÇÔ·® : 6-10 mg 
 
 -  Èí¼ö : 60-80% : ½ÊÀÌÁöÀå¿¡¼ Èí¼öµÊ 
	À¯±â SeÀÌ °¡Àå Àß Èí¼öµÇ¸ç ¹«±â Se´Â Àß Èí¼öµÇÁö ¾ÊÀ½
  
 -  ºÐÆ÷ : Ãʱ⿡ °£, ½ÅÀåÀ¸·Î ºÐÆ÷ÇÑ ÈÄ ±ÙÀ°, ÇǺÎ, ¼Õ, ¹ßÅéÀ¸·Î ºÐÆ÷ÇÔ
 
 -  ¼Ò½Ç : ´¢, ´ëº¯, È£Èí±â, ÇǺÎ
   
 Manganese sulfateÀÇ ¾à¹°µ¿·ÂÇÐÀÚ·á 
-  ü³»ÇÔ·® : 12-20 mg 
 
 -  Èí¼ö : 10%, ½ÊÀÌÁöÀå¿¡¼ Èí¼öµÊ, °áÇ̽à Èí¼ö°¡ Áõ°¡, Ä®½·¿¡ ÀÇÇØ °¨¼Ò  
 
 -  ºÐÆ÷ : transmanganinÀÇ À̵¿´Ü¹é¿¡ °áÇÕÇϸç, ±¤¹üÀ§ÇÏ°Ô ºÐÆ÷ÇÔ
	¹ÌÅäÄܵ帮¾Æ°¡ ¸¹Àº Á¶Á÷ - ³ú, ½ÅÀå, ÃéÀå, °£-¿¡ °í³óµµ·Î ºÐÆ÷  
 -  ¼Ò½Ç : ´ãÁó¹è¼³, ´ãÁóÆó¼â½Ã¿¡´Â ÃéÀå¾×À¸·Î ¹è¼³µÇ°Å³ª À§Àå°üÀ» ÅëÇØ ÀçÈí¼öµÊ
   
     | 
   
  
   
    CYP450  Drug Interaction | 
    
      [CYP450 TableÁ÷Á¢Á¶È¸] 
     | 
   
  
   
    | Drug-Induced Toxicity Related Proteins | 
    
      BETA-CAROTENE ÀÇ Drug-Induced Toxicity Related ProteinÁ¤º¸ Replated Protein:Thrombomodulin  Drug:beta-carotene Toxicity:endothelium dysfunction.  [¹Ù·Î°¡±â] Replated Protein:Von Willebrand factor  Drug:beta-carotene Toxicity:endothelium dysfunction.  [¹Ù·Î°¡±â] SELENIUM ÀÇ Drug-Induced Toxicity Related ProteinÁ¤º¸ Replated Protein:Thrombomodulin  Drug:selenium  Toxicity:endothelium dysfunction.  [¹Ù·Î°¡±â] Replated Protein:Von Willebrand factor  Drug:selenium  Toxicity:endothelium dysfunction.  [¹Ù·Î°¡±â] 
     | 
   
    
  |  
     
     
  
    
       |  
      
        
          
            
                | »ç¿ëÀÚÄÁÅÙÃ÷ |           
             
           
         | 
             	  
       |  
       |  
     
         
 
     | 
   
   
     | 
   
  
    
      
        
          
            
              - 
                ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2023-03-11
              
 
              - 
                
                 º» ¼öÁ¤ÀÏ Á¤º¸´Â Çã°¡Á¤º¸ ÀÌ¿ÜÀÇ ±âŸÁ¤º¸ ¼öÁ¤ÀÏÀ» ÀǹÌÇϹǷÎ, Çã°¡Á¤º¸¼öÁ¤ÀÏÀº º»¹®¿¡ Ç¥±âµÈ ³¯Â¥¸¦ ÂüÁ¶ÇϽñ⠹ٶø´Ï´Ù.
                
              
     
             
         |                 
       
     |       
          
                
                    
                       ¾Ë¸² | 
                       
                      »ó¼¼Á¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×À» Åä´ë·Î ÀÛ¼ºµÇ¾úÀ¸¸ç ¿ä¾àÁ¤º¸´Â »ó¼¼Á¤º¸ ¹× ±âŸ¹®ÇåÀ» ±â¹ÝÀ¸·Î µå·°ÀÎÆ÷¿¡¼ ÆíÁýÇÑ ³»¿ëÀÔ´Ï´Ù. Á¦Ç°Çã°¡»çÇ×ÀÇ ¸ñÂ÷¿Í ´Ù¼Ò »óÀÌÇÒ ¼ö ÀÖ½À´Ï´Ù.  | 
                    
                    | 
               
      
      
                
                    
                       °æ°í | 
                     
                      µå·°ÀÎÆ÷ ÀǾàÇмúÁ¤º¸´Â ½ÄǰÀǾàǰ¾ÈÀüóÀÇ Á¦Ç°Çã°¡»çÇ×, Çмú¹®Çå, Á¦¾àȸ»ç Á¦°øÁ¤º¸ µîÀ» ±Ù°Å·Î ÀÛ¼ºµÈ Âü°í Á¤º¸ÀÔ´Ï´Ù. 
                          Á¤º¸ÀÇ Á¤È®¼ºÀ» À§ÇØ ³ë·ÂÇϰí ÀÖÀ¸³ª ÆíÁý»óÀÇ ¿À·ù, Çã°¡»çÇ× º¯°æ, Ãß°¡ÀûÀÎ Çмú¿¬±¸ ¶Ç´Â Àӻ󿬱¸ ¹ßÇ¥ µîÀ¸·Î ÀÎÇØ ¹ß»ýÇÏ´Â ¹®Á¦¿¡ ´ëÇØ µå·°ÀÎÆ÷´Â 
                          Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. ÀÚ¼¼ÇÑ ³»¿ëÀº ¡°Ã¥ÀÓÀÇ ÇÑ°è ¹× ¹ýÀû°íÁö¡±¸¦ ÂüÁ¶ÇØ ÁֽʽÿÀ.
                            ¹Ýµå½Ã Á¦Á¶¡¤¼öÀÔ»ç, ÆÇ¸Å»ç, ÀÇ»ç, ¾à»ç¿¡°Ô ÃÖÁ¾ÀûÀ¸·Î È®ÀÎÇϽñ⠹ٶø´Ï´Ù.
                          ÀüÈ: 02-3486-1061 ¤Ó À̸ÞÀÏ: webmaster@druginfo.co.kr
 | 
  
                    | 
               
  
 
  
    ¾Æ·¡ÀÇ ³»¿ëÀ» Æ÷ÇÔÇÑ Àüü µ¥ÀÌÅ͸¦ º¸½Ã·Á¸é 
    ¿©±â·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
   
  
 
  º´¿ë±Ý±â ¹× ƯÁ¤¿¬·É´ë ±Ý±â ¼ººÐ
 
 |